Archive: 12/04/2018
US approves artificial-intelligence device for diabetic eye problems
US regulators Wednesday approved the first device that uses artificial intelligence to detect eye damage from diabetes, allowing regular doctors to diagnose the condition without interpreting any data or images.
Apr 12, 2018
Alectinib provides longer symptom improvement than crizotinib in ALK-positive lung cancer
Alectinib provides longer symptom improvement than crizotinib in ALK-positive non-small-cell lung cancer (NSCLC), according to results from the ALEX trial presented at the ELCC 2018 (European Lung Cancer Congress) in Geneva, ...
Apr 12, 2018